David A. Siegel Merus N.V. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Merus N.V. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 718,500 shares of MRUS stock, worth $42.5 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
718,500
Previous 431,500
66.51%
Holding current value
$42.5 Million
Previous $11.9 Million
172.66%
% of portfolio
0.08%
Previous 0.03%
Shares
18 transactions
Others Institutions Holding MRUS
# of Institutions
164Shares Held
47.9MCall Options Held
123KPut Options Held
293K-
Commodore Capital LP New York, NY4.36MShares$258 Million16.96% of portfolio
-
Rtw Investments, LP New York, NY4.11MShares$243 Million2.97% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.65MShares$157 Million2.46% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.25MShares$133 Million0.24% of portfolio
-
Samlyn Capital, LLC New York, NY2.08MShares$123 Million1.66% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.71B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...